E. Akaho 2022. Development of Cyclic Tetrapeptide as an EGFR Tyrosine Kinase Inhibitor Assayed by ELISA Experiment and Docking Study: A Novel Approach. Challenges and Advances in Pharmaceutical Research Vol. 2. (Apr. 2022), 108–121. DOI:https://doi.org/10.9734/bpi/capr/v2/1757A.